Pharmacogenomics and adverse drug reactions: the case of statins

Author： Giorgi Mariano A   Caroli Christian   Arazi Hernáán Cohen   Di Girolamo Guillermo  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.10, 2011-07, pp. : 1499-1509

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics and pharmacogenomics: adverse drug reactions

By Jorgensen Andrea   Alfirevic Ana  

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1397-1401

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of adverse drug reactions: practical applications and perspectives

By Becquemont Laurent  

Pharmacogenomics, Vol. 10, Iss. 6, 2009-06 ,pp. : 961-969

Future Medicine

Access to resources Recommend Favorite

Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents

By Meletiadis Joseph   Chanock Stephen   Walsh Thomas J  

Pharmacogenomics, Vol. 9, Iss. 5, 2008-05 ,pp. : 561-584

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics and active surveillance for serious adverse drug reactions in children

By Loo Tenneille T   Ross Colin JD   Sistonen Johanna   Visscher Henk   Madadi Parvaz   Koren Gideon   Hayden Michael R   Carleton Bruce C  

Pharmacogenomics, Vol. 11, Iss. 9, 2010-09 ,pp. : 1269-1285

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of severe cutaneous adverse reactions

By Kaniwa Nahoko   Saito Yoshiro  

Pharmacogenomics, Vol. 14, Iss. 6, 2013-04 ,pp. : 595-598

Future Medicine

Access to resources Recommend Favorite